🇸🇰 Medical cannabis in Slovakia

Model E — cannabinoid medicines only. Cannabis is not a medical category in Slovak law; the three-group system reserves Group I for substances that are not active ingredients of any medicine and bars their clinical use.

Zákon č. 139/1998 Z. z. o omamných látkach, psychotropných látkach a prípravkoch (Act on Narcotic Substances, Psychotropic Substances and Preparations), consolidated as of 1 January 2026: § 3 ods. 2 — 'Do I. skupiny sa zaraďujú omamné látky a psychotropné látky, ktoré nie sú obsiahnuté ako liečivo v lieku. Do II. skupiny … s vysokou návykovosťou, ktoré sú obsiahnuté ako liečivo v lieku. Do III. skupiny … s nižšou návykovosťou, ktoré sú obsiahnuté ako liečivo v lieku.' § 4 ods. 3 — Group I substances may be cultivated, produced, imported, exported, dispensed, transited and wholesaled 'iba na účely výskumnej, výučbovej a expertíznej činnosti s výnimkou pestovania konopy na priemyselné účely'. Amending acts since 2020: 372/2019, 124/2021, 479/2021, 532/2021, 391/2022, 246/2024, 293/2025 Z. z. — none creates a cannabis programme.

Source: Zákon č. 139/1998 Z. z. o omamných látkach, psychotropných látkach a prípravkoch (Act on Narcotic and Psychotropic Substances and Preparations), consolidated 2026-01-01, Slov-Lex static portal · read 27 September 2026

Only authorised finished medicines whose active substance sits in Group II/III of the schedules (THC/dronabinol-type medicines) or is unscheduled (cannabidiol, e.g. centrally authorised Epidyolex). Cannabis flower, extracts and pharmacy compounding: no. Whether Sativex is currently registered, marketed or reimbursed in Slovakia could not be verified from ŠÚKL's database in this session.

Cannabidiol was deleted from the schedule of Group II psychotropic substances by Zákon č. 124/2021 Z. z. (effective 1 May 2021), which removed the entry 'Cannabidiol, CBD, chemically 2-/[(1R,6R)-6-isopropenyl-3-methylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol' from Príloha č. 1 while adding synthetic cannabinoids and fentanyl analogues. The exact current placement of 'konope', 'konopná živica' and 'tetrahydrokanabinol/dronabinol' in Príloha č. 1 could not be displayed (the annex was beyond the portion of the page/PDF returned), so the group of each cannabis entry is stated from the Act's structure, not from the annex lines. The ŠÚKL (Štátny ústav pre kontrolu liečiv, State Institute for Drug Control) database search only returned its form to this session.

Source: Zákon č. 124/2021 Z. z., ktorým sa mení a dopĺňa zákon č. 139/1998 Z. z. (2021 amendment removing cannabidiol from the schedules), effective 2021-05-01 · read 27 September 2026

Any physician may prescribe an authorised Group II medicine on the special narcotic prescription form; product-specific prescribing restrictions (e.g. specialist-only) come from the product's registration and reimbursement decision, which could not be checked for any cannabinoid medicine in this session.

Zákon č. 362/2011 Z. z. o liekoch a zdravotníckych pomôckach (Act on Medicinal Products and Medical Devices) governs prescribing; Group II narcotic medicines are prescribed on the 'osobitné tlačivo lekárskeho predpisu označené šikmým modrým pruhom' (special prescription form with a blue diagonal stripe) or its electronic equivalent. The relevant §§ 119–120 were beyond the portion of the consolidated text returned in this session, so validity days and quantity caps are not quoted. No list of authorised cannabis prescribers exists because there is no cannabis pathway.

Source: Zákon č. 362/2011 Z. z. o liekoch a zdravotníckych pomôckach (Act on Medicinal Products and Medical Devices), consolidated 2026-01-01, Slov-Lex static portal · read 27 September 2026

Medicines with Group II substances need the special blue-striped narcotic prescription (paper or e-prescription in the ezdravie system); the statutory validity period and limits were not verified in this session.

The Medicines Act § 119–120 set the prescription form and validity; § 120a covers cross-border prescriptions. The consolidated text on the static Slov-Lex portal was truncated before these sections, so numbers are not quoted here.

Source: Zákon č. 362/2011 Z. z. (Act on Medicinal Products and Medical Devices), consolidated 2026-01-01 · read 27 September 2026

Not published for cannabinoid medicines; Slovakia has e-prescriptions (ezdravie) but no official statement on starting a Group II medicine after a remote consultation was found.

No regulator or ministry page on remote prescribing of narcotic medicines was reachable in this session (Ministry of Health site blocked automated access).

Source: Zákon č. 362/2011 Z. z. (Act on Medicinal Products and Medical Devices) · read 27 September 2026

Public pharmacies dispense authorised narcotic medicines against the special prescription; no pharmacy may dispense cannabis flower or extracts because Group I substances may be dispensed only for research, teaching or expert activity.

§ 4 ods. 3 of Act 139/1998: Group I substances may be dispensed ('vydávať') only for research, teaching and expert purposes. § 3 ods. 3–4: exempt preparations ('vyňaté prípravky') containing Group II/III substances in the quantities of Príloha č. 2 fall outside §§ 19–22 and § 28. No compounding or mail-order route for cannabis exists.

Source: Zákon č. 139/1998 Z. z., § 3 and § 4 · read 27 September 2026

Not verified. Reimbursement in Slovakia follows the Ministry of Health's categorisation list (zoznam kategorizovaných liekov); whether any cannabinoid medicine is currently categorised could not be checked because the ministry's site blocked automated access.

The Ministry of Health (Ministerstvo zdravotníctva SR) publishes the categorisation list; requests to health.gov.sk timed out at robots.txt in this session. No official statement on reimbursement of Sativex or Epidyolex was opened.

Source: Zákon č. 362/2011 Z. z. (Act on Medicinal Products and Medical Devices) · read 27 September 2026

No public price verified; official prices sit in the ŠÚKL database and the categorisation list, neither of which returned data in this session.

ŠÚKL's advanced search (rozšírené vyhľadávanie) is form-driven and returned no product rows to automated requests.

Source: ŠÚKL — Rozšírené vyhľadávanie (advanced search of the medicines database) · read 27 September 2026

Slovakia applies an effective zero-tolerance rule: a driver may not take a narcotic/addictive substance while driving and may not drive at any time after taking one while it could still be in the body. There is no written exception for THC taken on prescription.

Zákon č. 8/2009 Z. z. o cestnej premávke (Road Traffic Act), § 4 ods. 2: písm. c) a driver must not 'požiť počas vedenia vozidla alkohol alebo inú návykovú látku'; písm. d) must not drive 'v takom čase po požití alkoholu [alebo inej návykovej látky] … keď sa … ešte môžu nachádzať v jeho organizme'; písm. f) must not drive when ability is reduced by injury, illness, nausea or fatigue. No numeric THC threshold and no prescription defence appear in § 4. 'Návyková látka' is not defined in this Act (it relies on the general definition in other legislation).

Source: Zákon č. 8/2009 Z. z. o cestnej premávke (Road Traffic Act), consolidated 2026-01-01, PDF · read 27 September 2026

Slovakia is a Schengen state, so the Schengen Art. 75 certificate (max 30 days) is the instrument for bringing a narcotic medicine in from another Schengen country; the Slovak issuing authority, form and the rule for non-Schengen arrivals are published by the Ministry of Health, whose pages could not be opened in this session. Cannabis flower is Group I and may not be brought in at all.

Act 139/1998 contains no traveller provision (§§ 19–22 and § 28 concern licensed import/export); personal import rules for patients are handled administratively by the Ministerstvo zdravotníctva SR under the Schengen Convention. health.gov.sk timed out on robots.txt and the customs (Finančná správa) travel page returned 404, so issuer, quantities and non-Schengen permits are not verified.

Source: Zákon č. 139/1998 Z. z., §§ 19–28 (no traveller provision) · read 27 September 2026

No one — resident or visitor — can obtain cannabis flower or extracts in Slovakia. A prescription from another EU country is recognised under § 120a of the Medicines Act, but narcotic medicines on special prescription forms are the standard exclusion; the exact Slovak wording could not be displayed. Bring your own authorised medicine with a Schengen Art. 75 certificate.

1) Non-residents: no residency bar is published for authorised cannabinoid medicines; the practical gate is a Slovak-licensed prescriber and the special narcotic prescription — not published beyond that. 2) Foreign EU/EEA prescriptions: Zákon č. 362/2011 Z. z. § 120a 'Lekársky predpis a lekársky poukaz na poskytovanie cezhraničnej zdravotnej starostlivosti' transposes Directive 2011/24/EU Art. 11 (inserted by Zákon č. 220/2013 Z. z., effective 1 October 2013); the section heading was confirmed but its exclusions (Art. 11(6) — medicines on the special blue-striped narcotic form) were beyond the returned text — not verified. 3) Bringing medicine in: Schengen residents — Art. 75 certificate, max 30 days; non-Schengen/non-EU — Ministry of Health rule not reachable — not published here. Cannabis flower cannot be imported (Group I). 4) Foreign telemedicine prescriptions: follow 2); a foreign prescription for a Group II medicine is not expected to be dispensable, but the statutory text was not verified.

Source: Zákon č. 362/2011 Z. z. o liekoch a zdravotníckych pomôckach — § 120a (cross-border prescriptions), consolidated 2026-01-01 · read 27 September 2026

The Act was last amended by 293/2025 Z. z. (consolidated 1 January 2026) with no cannabis-programme provision; no pending medical-cannabis bill could be checked in this session.

Amendments since 2020 (372/2019, 124/2021, 479/2021, 532/2021, 391/2022, 246/2024, 293/2025 Z. z.) adjusted schedules and administrative duties; the only cannabis-relevant change was the 2021 removal of CBD. The Národná rada bill register was not consulted.

Source: Zákon č. 139/1998 Z. z., consolidated 2026-01-01 (amendment history) · read 27 September 2026

No official count exists; there are no legal cannabis patients and no published figure for patients on cannabinoid medicines was found.

Neither ŠÚKL nor the Ministry of Health pages reachable in this session publish such numbers.

Source: ŠÚKL — Rozšírené vyhľadávanie (medicines database) · read 27 September 2026